Dickkopf1 fuels inflammatory cytokine responses

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Inflammation is a key component of many diseases, including cancer.
• The molecular mechanisms driving inflammation are not fully understood.
• Dickkopf1 (DKK1) is implicated in various cellular processes.

Purpose of the Study:

• To investigate the role of Dickkopf1 (DKK1) in regulating inflammatory cytokine responses.
• To elucidate the cell-autonomous mechanisms by which DKK1 influences inflammation.
• To translate findings from preclinical models to human populations.

Main Methods:

• Utilized cell models, mice, and human genetic data.
• Investigated DKK1 activity in response to toll-like and cytokine receptor ligation.
• Analyzed the role of SOCS3-restricted nuclear RelA (p65) activity.
• Assessed the impact of genetic DKK1 deletion versus pharmacological neutralization in a mouse model of endotoxemia.

Main Results:

• Physiological and pathological DKK1 activity promotes inflammatory cytokine production.
• DKK1 maintains the inflammatory tone in cancer cells and is essential for receptor-mediated cytokine responses.
• DKK1-controlled inflammation involves cell-autonomous mechanisms including SOCS3-restricted nuclear RelA (p65) activity.
• Genetic DKK1 variants correlate with elevated cytokine production in humans.
• Genetic deletion of DKK1, but not soluble DKK1 neutralization, ameliorated inflammation and disease in mice.

Conclusions:

• DKK1 possesses a conserved cell-autonomous function in controlling inflammatory responses in both malignant and non-malignant cells.
• DKK1 is a significant mediator of inflammation, offering potential therapeutic targets.
• Further research is needed to fully understand DKK1 trafficking and signaling pathways.